Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation
Showkat A. Haji, Randall C. Starling, Robin K. Avery, Steven Mawhorter, E. Murat Tuzcu, Paul Schoenhagen, Daniel J. Cook, Norman B. Ratliff, Patrick M. McCarthy, James B. Young, Mohamad H. Yamani*
Dive into the research topics of 'Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation'. Together they form a unique fingerprint.